<code id='786AB46D80'></code><style id='786AB46D80'></style>
    • <acronym id='786AB46D80'></acronym>
      <center id='786AB46D80'><center id='786AB46D80'><tfoot id='786AB46D80'></tfoot></center><abbr id='786AB46D80'><dir id='786AB46D80'><tfoot id='786AB46D80'></tfoot><noframes id='786AB46D80'>

    • <optgroup id='786AB46D80'><strike id='786AB46D80'><sup id='786AB46D80'></sup></strike><code id='786AB46D80'></code></optgroup>
        1. <b id='786AB46D80'><label id='786AB46D80'><select id='786AB46D80'><dt id='786AB46D80'><span id='786AB46D80'></span></dt></select></label></b><u id='786AB46D80'></u>
          <i id='786AB46D80'><strike id='786AB46D80'><tt id='786AB46D80'><pre id='786AB46D80'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:3663
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Cholera vaccine supplies dangerously low, outbreaks surging
          Cholera vaccine supplies dangerously low, outbreaks surging

          AhealthworkerholdsasampleofcholeravaccineinHarare,Zimbabwe.JEKESAINJIKIZANA/AFPviaGettyImagesAnunpre

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Readout Newsletter: The latest on Amylyx, Moderna, Novavax

          JUSTINTALLIS/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toge